Enzyme replacement therapy for mucopolysaccharidosis VI: Long-term cardiac effects of galsulfase (Naglazyme®) therapy

  • E. Braunlin
  • , H. Rosenfeld
  • , C. Kampmann
  • , J. Johnson
  • , M. Beck
  • , R. Giugliani
  • , N. Guffon
  • , D. Ketteridge
  • , C. M. Sá Miranda
  • , M. Scarpa
  • , I. V. Schwartz
  • , E. Leão Teles
  • , J. E. Wraith
  • , P. Barrios
  • , E. Dias Da Silva
  • , G. Kurio
  • , M. Richardson
  • , G. Gildengorin
  • , J. J. Hopwood
  • , M. Imperiale
    • A. Schatz, C. Decker, P. Harmatz

Research output: Contribution to journal › Article › peer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'Enzyme replacement therapy for mucopolysaccharidosis VI: Long-term cardiac effects of galsulfase (Naglazyme®) therapy'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science